Longeveron Inc (OQ:LGVN)

Business Focus: Biotechnology & Medical Research

Insider Chart - Past 6 Months
Latest 10 SEC filings (by transaction date) for LGVN within the last 6 months
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 6th, 2025
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 6/25 Jan 2/25 Agafonova Nataliya Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -6,120 $1.79
Jan 6/25 Jan 2/25 Hashad Mohamed Wa'el Ahmed Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -10,827 $1.79
Jan 6/25 Jan 2/25 Locklear Lisa Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -6,120 $1.79
Jan 6/25 Jan 2/25 Lehr Paul T Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,205 $1.79
Dec 4/24 Dec 2/24 Baluch Khoso Direct Ownership Class A Common Stock S - Open market or private sale -1,250 $2.07
Oct 3/24 Oct 1/24 Locklear Lisa Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -5,316 $1.88
Oct 3/24 Oct 1/24 Agafonova Nataliya Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -5,316 $1.88
Oct 3/24 Oct 1/24 Lehr Paul T Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -990 $1.88
Oct 3/24 Oct 1/24 Hashad Mohamed Wa'el Ahmed Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -13,357 $1.88
Aug 19/24 Aug 15/24 Agafonova Nataliya Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 16,250  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for LGVN within the last 6 months
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 6th, 2025
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 6/25 Jan 2/25 Agafonova Nataliya Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -6,120 $1.79
Jan 6/25 Jan 2/25 Hashad Mohamed Wa'el Ahmed Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -10,827 $1.79
Jan 6/25 Jan 2/25 Locklear Lisa Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -6,120 $1.79
Jan 6/25 Jan 2/25 Lehr Paul T Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,205 $1.79
Dec 4/24 Dec 2/24 Baluch Khoso Direct Ownership Class A Common Stock S - Open market or private sale -1,250 $2.07
Oct 3/24 Oct 1/24 Locklear Lisa Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -5,316 $1.88
Oct 3/24 Oct 1/24 Agafonova Nataliya Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -5,316 $1.88
Oct 3/24 Oct 1/24 Lehr Paul T Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -990 $1.88
Oct 3/24 Oct 1/24 Hashad Mohamed Wa'el Ahmed Direct Ownership Class A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -13,357 $1.88
Aug 19/24 Aug 15/24 Agafonova Nataliya Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 16,250  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $LGVN

  • No tweets found

Competitors

Competitors with Recent Insider Filings
United Therapeutics (OQ:UTHR)
Revolution Medicines (OQ:RVMD)
CG Oncology (OQ:CGON)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.